Compare SSBI & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SSBI | XTNT |
|---|---|---|
| Founded | 1982 | N/A |
| Country | United States | United States |
| Employees | 106 | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 86.7M | 88.7M |
| IPO Year | N/A | 2009 |
| Metric | SSBI | XTNT |
|---|---|---|
| Price | $13.30 | $0.55 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $1.50 |
| AVG Volume (30 Days) | 3.9K | ★ 116.1K |
| Earning Date | 04-28-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.03 |
| Revenue | N/A | ★ $53,337,000.00 |
| Revenue This Year | N/A | $15.08 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $13.23 | $18.87 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.60 | $0.34 |
| 52 Week High | $14.00 | $0.95 |
| Indicator | SSBI | XTNT |
|---|---|---|
| Relative Strength Index (RSI) | 59.19 | 37.77 |
| Support Level | $12.73 | N/A |
| Resistance Level | $13.58 | $0.68 |
| Average True Range (ATR) | 0.20 | 0.04 |
| MACD | 0.04 | -0.00 |
| Stochastic Oscillator | 100.00 | 5.37 |
Summit State Bank provides various banking products and services to individuals and businesses in Sonoma County, California. It offers personal and business checking, money market, sweep, savings, and demand accounts; time certificates of deposit; and specialized deposit accounts, such as professional, small business packaged, tiered, and retirement plan accounts. The company also provides loans, including commercial loans and leases; lines of credit; commercial real estate, small business administration, residential mortgage, and construction loans; home equity lines of credit; and term and equipment loans, as well as loans to agriculture-related businesses.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.